Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00755_DB01023_nanopub.RA_E4cI9jtg-sGf_aSIcGVQcQIeapcmAfm8kGkF97gM8o#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00755_DB01023 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00755_DB01023 label "DDI between Tretinoin and Felodipine - The moderate CYP2C8 inhibitor, Felopidine, may decrease the metabolism and clearance of oral Tretinoin. Monitor for changes in Tretinoin effectiveness and adverse/toxic effects if Felopidine is initiated, discontinued to dose changed. [drugbank_resource:DB00755_DB01023]" assertion.
- drugbank_resource:DB00755_DB01023 identifier "drugbank_resource:DB00755_DB01023" assertion.
- drugbank_resource:DB00755_DB01023 title "DDI between Tretinoin and Felodipine - The moderate CYP2C8 inhibitor, Felopidine, may decrease the metabolism and clearance of oral Tretinoin. Monitor for changes in Tretinoin effectiveness and adverse/toxic effects if Felopidine is initiated, discontinued to dose changed." assertion.
- drugbank:DB01023 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00755_DB01023 assertion.
- drugbank:DB00755 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00755_DB01023 assertion.